Related Experiment Video
Updated: May 2, 2026

Double-barreled and Concentric Microelectrodes for Measurement of Extracellular Ion Signals in Brain Tissue
Published on: September 5, 2015
Blockade of a resting potassium channel and modulation of synaptic transmission by ecstasy in the hippocampus
1Department of Membrane Physiology and Biophysics, John Curtin School of Medical Research, Australian National University, Canberra.
Abstract:
3,4-Methylenedioxymethamphetamine (ecstasy, MDMA) and related amphetamines are CNS stimulants that have euphoric, memory-enhancing and neurotoxic properties. When applied in pharmacological doses to cultured rat hippocampal neurons, ecstasy reduced the conductance of a 50-pS barium-sensitive resting K+ channel and increased neuronal excitability. Ecstasy enhanced synaptic strength by irreversibly increasing the amplitude of excitatory autaptic currents and the frequency of spontaneous excitatory postsynaptic currents. Ecstasy did not alter the amplitude of inhibitory autaptic currents or the frequency of spontaneous inhibitory postsynaptic currents but reversibly prolonged the decay phase of inhibitory autaptic currents and spontaneous inhibitory postsynaptic currents. These results suggest that K+ channel blockade and the effects on synaptic transmission may contribute to the pharmacological effects of ecstasy and other amphetamines.
More Related Videos
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
04:44Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice
Published on: February 16, 2024
Related Concept Videos
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
CNS Stimulants: Psychedelic Agents
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...